Stay updated on Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.

Latest updates to the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page
- Check4 days agoChange DetectedThe study record for the ZW25 (zanidatamab) trial is displayed, with details on its treatment phases, participant criteria, study locations, and outcomes. It indicates the trial is completed and no longer recruiting.SummaryDifference73%

- Check11 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study record continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page now shows ClinicalTrials.gov navigation and a general NIH announcement about terminology changes, rather than the prior 403 error message. No study-specific details are displayed.SummaryDifference2%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record. The screen shows a basic 403 message with a Home link, indicating the page is not accessible.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record, with a Home link visible. This indicates an access issue rather than a content update to the study details.SummaryDifference21%

Stay in the know with updates to Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.